ACZONE
Drug
Allergan Inc.
Total Payments
$1.9M
Transactions
4,913
Doctors
1,950
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $35,478 | 1 | 0 |
| 2019 | $52,004 | 5 | 0 |
| 2018 | $81,730 | 39 | 11 |
| 2017 | $1.7M | 4,868 | 1,945 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $881,116 | 370 | 46.1% |
| Unspecified | $752,146 | 172 | 39.4% |
| Food and Beverage | $158,896 | 3,952 | 8.3% |
| Travel and Lodging | $76,243 | 403 | 4.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $42,175 | 10 | 2.2% |
| Education | $300.20 | 6 | 0.0% |
Payments by Type
General
$1.2M
4,741 transactions
Research
$752,146
172 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| SAFETY AND EFFICACY TRIAL OF ACZONE DAPSONE GEL, 7.5 IN 9 TO 11 YEAR-OLD PATIENTS WITH ACNE VULGARIS | Allergan Inc. | $636,874 | 0 |
| ACZONE GEL IN THE TREATMENT OF ACNE VULGARIS | Almirall LLC | $52,004 | 0 |
| An open-label study to investigate the efficacy and tolerability of Aczone gel, 7.5% in the treatment of acne vulgaris in men and women with Fitzpatrick skin types IV-VI | Almirall LLC | $35,478 | 0 |
| An open-label study to investigate the efficacy and tolerability of Aczone gel, 7.5 in the treatment of acne vulgaris in men and women with Fitzpatrick skin types IV-VI | Allergan Inc. | $24,291 | 0 |
| Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris | Allergan Inc. | $3,500 | 0 |
Top Doctors Receiving Payments for ACZONE — Page 74
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Dermatology | Norfolk, VA | $12.18 | 1 |
| , M.D | Dermatology | Norfolk, VA | $12.18 | 1 |
| , M.D | Dermatology | Fort Collins, CO | $12.16 | 1 |
| , M.D | Dermatology | Colorado Springs, CO | $12.12 | 1 |
| , MD | MOHS-Micrographic Surgery | Colorado Springs, CO | $12.12 | 1 |
| , M.D | Dermatology | Clarks Summit, PA | $12.10 | 1 |
| , M.D | Dermatology | Clarks Summit, PA | $12.10 | 1 |
| , MD | Specialist | Charleston, WV | $12.09 | 1 |
| , MD | Specialist | New York, NY | $12.08 | 1 |
| , M.D | Dermatology | Bellaire, TX | $12.01 | 1 |
| , M.D | Dermatology | Birmingham, MI | $12.01 | 1 |
| , M.D | Dermatology | Bellaire, TX | $12.01 | 1 |
| , M.D | Dermatology | Bellaire, TX | $12.01 | 1 |
| , D.O | Dermatology | Bellaire, TX | $12.01 | 1 |
| , M.D | Dermatology | Torrance, CA | $12.01 | 1 |
| , M.D | Dermatology | Charleston, SC | $11.97 | 1 |
| , M.D | Specialist | Saratoga Springs, NY | $11.95 | 1 |
| , M.D | Dermatology | Merced, CA | $11.94 | 1 |
| , DO | Dermatology | Twinsburg, OH | $11.93 | 3 |
| , M.D | Dermatology | Paducah, KY | $11.93 | 1 |
| , M.D | Dermatology | Richardson, TX | $11.88 | 1 |
| , M.D | Dermatology | Plano, TX | $11.88 | 1 |
| , M.D | Dermatology | Valparaiso, IN | $11.79 | 1 |
| , M.D | Dermatology | New Orleans, LA | $11.79 | 1 |
| , M.D | Dermatology | Metairie, LA | $11.79 | 1 |
Ad
Manufacturing Companies
- Allergan Inc. $1.8M
- Almirall LLC $87,481
Product Information
- Type Drug
- Total Payments $1.9M
- Total Doctors 1,950
- Transactions 4,913
About ACZONE
ACZONE is a drug associated with $1.9M in payments to 1,950 healthcare providers, recorded across 4,913 transactions in the CMS Open Payments database. The primary manufacturer is Allergan Inc..
Payment data is available from 2017 to 2020. In 2020, $35,478 was paid across 1 transactions to 0 doctors.
The most common payment nature for ACZONE is "Consulting Fee" ($881,116, 46.1% of total).
ACZONE is associated with 5 research studies, including "SAFETY AND EFFICACY TRIAL OF ACZONE DAPSONE GEL, 7.5 IN 9 TO 11 YEAR-OLD PATIENTS WITH ACNE VULGARIS" ($636,874).